{"anticipatedPostingDate":"2027-03","denomUnitsSelected":"Participants","description":"PFS2 is defined as the time from randomization to disease progression as assessed by investigator on next-line treatment or death from any cause (whichever occurred first). Data for this outcome measure will be reported after study completion (anticipated study completion date is March 2026)","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 69 months","title":"PFS on Next-line of Therapy (PFS2)","type":"SECONDARY"}